Suven Life Sciences Limited (NSE:SUVEN)
India · Delayed Price · Currency is INR 291.02
+0.83 (0.29%)
Jul 18, 2025, 3:30 PM IST
Suven Life Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 377.26 | 149.32 | 370.19 | 52.74 | 93.48 | Upgrade |
Short-Term Investments | 222.79 | 1,490 | 1,451 | - | 369.2 | Upgrade |
Trading Asset Securities | - | 759.35 | 463.39 | 451.62 | 0.86 | Upgrade |
Cash & Short-Term Investments | 600.05 | 2,399 | 2,284 | 504.36 | 463.54 | Upgrade |
Cash Growth | -74.98% | 5.01% | 352.91% | 8.80% | 214.79% | Upgrade |
Accounts Receivable | 13.36 | 12.86 | 8.07 | 12.98 | 17.62 | Upgrade |
Other Receivables | 0.76 | 22.02 | 47.67 | 75.25 | 62.79 | Upgrade |
Receivables | 14.12 | 34.88 | 55.74 | 88.23 | 494.89 | Upgrade |
Inventory | 2.38 | 7.09 | 0.08 | 0.33 | 5.01 | Upgrade |
Prepaid Expenses | - | 5.9 | 3.57 | 4.33 | 4.12 | Upgrade |
Other Current Assets | 138.18 | 120.19 | 172.19 | 68.7 | 59.25 | Upgrade |
Total Current Assets | 754.72 | 2,567 | 2,516 | 665.95 | 1,027 | Upgrade |
Property, Plant & Equipment | 594.82 | 280.1 | 370.16 | 408.91 | 256.01 | Upgrade |
Long-Term Investments | - | - | 1,000 | - | - | Upgrade |
Other Intangible Assets | 1.81 | 1.99 | 1.98 | 2.25 | 1.36 | Upgrade |
Other Long-Term Assets | 0.49 | 0.21 | 1.1 | 3.25 | - | Upgrade |
Total Assets | 1,352 | 2,849 | 3,889 | 1,080 | 1,284 | Upgrade |
Accounts Payable | 52.27 | 20.68 | 16.65 | 19.87 | 29.96 | Upgrade |
Accrued Expenses | 22.43 | 106.91 | 82.48 | 40.19 | 92.02 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 4.84 | 9.44 | Upgrade |
Current Portion of Leases | - | 7.1 | 10.26 | 11.51 | 11.01 | Upgrade |
Current Unearned Revenue | - | - | - | 0.56 | 1.06 | Upgrade |
Other Current Liabilities | 160.16 | 0.47 | 1.91 | 6.18 | 15.61 | Upgrade |
Total Current Liabilities | 234.86 | 135.16 | 111.3 | 83.15 | 159.1 | Upgrade |
Long-Term Debt | - | - | - | - | 3.93 | Upgrade |
Long-Term Leases | - | - | 5.79 | 15.73 | 23.26 | Upgrade |
Long-Term Unearned Revenue | - | - | - | - | 0.56 | Upgrade |
Other Long-Term Liabilities | - | 13.46 | 15.05 | 12.05 | 6.93 | Upgrade |
Total Liabilities | 251.97 | 148.62 | 135.91 | 118.89 | 204.12 | Upgrade |
Common Stock | 218.07 | 218.07 | 218.07 | 145.38 | 127.28 | Upgrade |
Additional Paid-In Capital | - | 6,468 | 6,468 | 2,566 | 1,108 | Upgrade |
Retained Earnings | - | -3,965 | -2,914 | -1,733 | -511.47 | Upgrade |
Comprehensive Income & Other | 881.79 | -20.42 | -18.99 | -17.46 | 356.1 | Upgrade |
Shareholders' Equity | 1,100 | 2,700 | 3,753 | 961.45 | 1,080 | Upgrade |
Total Liabilities & Equity | 1,352 | 2,849 | 3,889 | 1,080 | 1,284 | Upgrade |
Total Debt | - | 7.1 | 16.05 | 32.09 | 47.64 | Upgrade |
Net Cash (Debt) | 600.05 | 2,392 | 2,268 | 472.27 | 415.9 | Upgrade |
Net Cash Growth | -74.91% | 5.44% | 380.28% | 13.55% | 377.36% | Upgrade |
Net Cash Per Share | 2.75 | 10.97 | 12.72 | 3.50 | 3.27 | Upgrade |
Filing Date Shares Outstanding | 217.55 | 218.07 | 218.07 | 145.38 | 127.28 | Upgrade |
Total Common Shares Outstanding | 217.55 | 218.07 | 218.07 | 145.38 | 127.28 | Upgrade |
Working Capital | 519.86 | 2,432 | 2,405 | 582.8 | 867.72 | Upgrade |
Book Value Per Share | 5.06 | 12.38 | 17.21 | 6.61 | 8.49 | Upgrade |
Tangible Book Value | 1,098 | 2,698 | 3,751 | 959.21 | 1,079 | Upgrade |
Tangible Book Value Per Share | 5.05 | 12.37 | 17.20 | 6.60 | 8.47 | Upgrade |
Land | - | 3.18 | 3.18 | 3.18 | 3.18 | Upgrade |
Machinery | - | 764.27 | 860.18 | 797.35 | 633.99 | Upgrade |
Construction In Progress | - | - | - | 35.51 | 47.74 | Upgrade |
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.